Conclusions Although studies have demonstrated the efficacy of GLP-1 receptor agonists (GLP-1 RAs) and SGLT-2 inhibitors in improving conditions associated with new-onset diabetes mellitus (DM) and chronic kidney disease (CKD), there is a scarcity of data regarding their use after liver transplantation
Yo revisara contigo el motivo del tratamiento, la evolucin del peso, la composicin corporal, la alimentacin, el ejercicio de fuerza y el control metablico antes de decidir si conviene ajustar o suspender
It can only be accessed through authorised clinical trials
Given that semaglutide can alter gut microbiome composition, probiotic supplementation may provide additional protection
Abbasinejad and the team provide structured guidance to help patients understand the typical Wegovy weight loss timeline
During the first 4-8 weeks, patients should anticipate a potential adjustment period characterized by gastrointestinal symptoms